Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease

Keywords: interstitial lung disease; lung function; paediatric lung disease; pulmonary vascular disease; sleep

[1]  G. Rossi,et al.  Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis. , 2016, American journal of respiratory and critical care medicine.

[2]  W. Morgan,et al.  Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function. , 2016, The Journal of pediatrics.

[3]  J. Heffner.  Chipping away at duration of therapy for idiopathic acute eosinophilic pneumonia , 2015, Respirology.

[4]  Se Jin Kim,et al.  Outcomes of rapid corticosteroid tapering in acute eosinophilic pneumonia patients with initial eosinophilia , 2015, Respirology.

[5]  J. Pillow,et al.  Gestational age at initial exposure to in utero inflammation influences the extent of diaphragm dysfunction in preterm lambs , 2015, Respirology.

[6]  Meenu Singh,et al.  Epidemiology and genetics of cystic fibrosis in Asia: In preparation for the next‐generation treatments , 2015, Respirology.

[7]  S. Fouzas,et al.  Increased β‐glucuronidase activity in bronchoalveolar lavage fluid of children with bacterial lung infection: A case–control study , 2015, Respirology.

[8]  J. Abbott,et al.  International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety , 2015, Thorax.

[9]  C. Shimbori,et al.  Molecular classification of idiopathic pulmonary fibrosis: Personalized medicine, genetics and biomarkers , 2015, Respirology.

[10]  G. Sawicki,et al.  Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data. , 2015, American journal of respiratory and critical care medicine.

[11]  M. Taguchi,et al.  Incidence and outcome of lung involvement in IgG4‐related autoimmune pancreatitis , 2015, Respirology.

[12]  C. Irvin,et al.  An epilogue to lung function and lung disease: State‐of‐the‐art 2015 , 2015, Respirology.

[13]  V. Sapin,et al.  Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end‐products in patients without pre‐existing lung injury , 2015, Respirology.

[14]  J. Pépin,et al.  Nasal obstruction and male gender contribute to the persistence of mouth opening during sleep in CPAP‐treated obstructive sleep apnoea , 2015, Respirology.

[15]  J. Kitzman,et al.  Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs. , 2015, Cell host & microbe.

[16]  J. Clancy,et al.  Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[17]  I. Korten,et al.  A big step forward in understanding global differences in respiratory health: First lung function data in African infants , 2015, Respirology.

[18]  R. Chambers,et al.  Role of a functional polymorphism in the F2R gene promoter in sarcoidosis , 2015, Respirology.

[19]  S. Diggle,et al.  A 1,000-Year-Old Antimicrobial Remedy with Antistaphylococcal Activity , 2015, mBio.

[20]  A. Holland.  Functional capacity in idiopathic pulmonary fibrosis: Looking beyond the lungs , 2015, Respirology.

[21]  A. Mangano,et al.  Post‐infectious bronchiolitis obliterans and mannose‐binding lectin insufficiency in Argentinean children , 2015, Respirology.

[22]  J. Stradling,et al.  Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta‐analysis , 2015, Respirology.

[23]  Yi Shi,et al.  Association between telomere length and survival in patients with idiopathic pulmonary fibrosis , 2015, Respirology.

[24]  K. Leslie,et al.  Histopathology of the idiopathic interstitial pneumonias (IIP): A review , 2015, Respirology.

[25]  Joseph Jacob,et al.  HRCT of fibrosing lung disease , 2015, Respirology.

[26]  S. Redline,et al.  The Sleep Apnea cardioVascular Endpoints (SAVE) Trial: Rationale, Ethics, Design, and Progress. , 2015, Sleep.

[27]  D. Brooks,et al.  Skeletal muscle atrophy in advanced interstitial lung disease , 2015, Respirology.

[28]  D. Postma,et al.  Association between peripheral airway function and neutrophilic inflammation in asthma , 2015, Respirology.

[29]  D. Chambers.  In the end it's a replication problem: What measuring telomere length can tell us about idiopathic pulmonary fibrosis , 2015, Respirology.

[30]  Shandra L. Protzko,et al.  An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. , 2015, American journal of respiratory and critical care medicine.

[31]  Steve Cunningham,et al.  Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial , 2015 .

[32]  J. Behr,et al.  Changes in the current classification of IIP: A critical review , 2015, Respirology.

[33]  M. Karagas,et al.  Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis. , 2015, The Journal of pediatrics.

[34]  Cheng-Li Lin,et al.  Association between pneumococcal pneumonia and venous thromboembolism in hospitalized patients: A nationwide population‐based study , 2015, Respirology.

[35]  L. Beckert,et al.  Pneumonia and venous thromboembolism: Is the evidence catching up with the guidelines? , 2015, Respirology.

[36]  H. Collard,et al.  Idiopathic interstitial pneumonias in 2015: A new era , 2015, Respirology.

[37]  B. Edwards,et al.  Evaluation of the role of lung volume and airway size and shape in supine‐predominant obstructive sleep apnoea patients , 2015, Respirology.

[38]  J. Pretto,et al.  Optimizing respiratory function assessments to elucidate the impact of obesity on respiratory health , 2015, Respirology.

[39]  M. Nishimura,et al.  Multi‐institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases , 2015, Respirology.

[40]  Yuanlin Song,et al.  Year in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung disease , 2015, Respirology.

[41]  C. Castellani,et al.  Inconclusive Diagnosis of Cystic Fibrosis After Newborn Screening , 2015, Pediatrics.

[42]  R. Ochiai.  Mechanical ventilation of acute respiratory distress syndrome , 2015, Journal of Intensive Care.

[43]  Marleen de Bruijne,et al.  PRAGMA-CF. A Quantitative Structural Lung Disease Computed Tomography Outcome in Young Children with Cystic Fibrosis. , 2015, American journal of respiratory and critical care medicine.

[44]  M. Bando,et al.  Physical activity in patients with idiopathic pulmonary fibrosis , 2015, Respirology.

[45]  J. Carlin,et al.  Statistical models for respiratory disease diagnosis and prognosis , 2015, Respirology.

[46]  T. Bartter,et al.  Seeing what we hear: an eye to help the ear , 2015, Respirology.

[47]  D. Saha,et al.  Novel algorithm to identify and differentiate specific digital signature of breath sound in patients with diffuse parenchymal lung disease , 2015, Respirology.

[48]  S. Stick,et al.  Early pulmonary inflammation and lung damage in children with cystic fibrosis , 2015, Respirology.

[49]  S. Macansh,et al.  Current Australasian practice for diagnosis and management of idiopathic pulmonary fibrosis: Where are we now? , 2015, Respirology.

[50]  Y. Kong,et al.  Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium , 2015, Nature Communications.

[51]  G. Koch,et al.  A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials , 2015, European Respiratory Journal.

[52]  L. Richeldi,et al.  Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro‐con perspective , 2015, Respirology.

[53]  M. Cloutier,et al.  Delayed access to treatments for rare diseases: Who's to blame? , 2015, Respirology.

[54]  Sindhu R. Johnson,et al.  Survival in rheumatoid arthritis‐associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension , 2015, Respirology.

[55]  N. Kohno,et al.  MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis , 2015, Respirology.

[56]  M. Brockhurst,et al.  Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections. , 2015, American journal of respiratory and critical care medicine.

[57]  K. Isobe,et al.  Effectiveness of combined therapy with pirfenidone and inhaled N‐acetylcysteine for advanced idiopathic pulmonary fibrosis: A case–control study , 2015, Respirology.

[58]  A. Nambiar,et al.  Combination pirfenidone and inhaled N‐acetylcysteine therapy for IPF: Does it take these two to tango? , 2015, Respirology.

[59]  S. Stanojevic,et al.  Effect of equipment dead space on multiple breath washout measures , 2015, Respirology (Carlton South. Print).

[60]  Sally J. Singh,et al.  Do we need a practice incremental shuttle walk test for patients with interstitial lung disease referred for pulmonary rehabilitation? , 2015, Respirology.

[61]  R. Marshall,et al.  Pharmaceutical industry, academia and patient advocacy organizations: What is the recipe for synergic (win–win–win) collaborations? , 2015, Respirology.

[62]  D. Mukherjee,et al.  Portopulmonary hypertension: An update , 2015, Respirology.

[63]  X. Tian,et al.  Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients , 2015, Respirology.

[64]  H. Zar,et al.  Respiratory impedance in healthy unsedated South African infants: Effects of maternal smoking , 2015, Respirology.

[65]  M. Kolb,et al.  Drug development for chronic lung disease ‐ Mission impossible? , 2015, Respirology.

[66]  H. Cai,et al.  Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population , 2015, Respirology.

[67]  J. Jagirdar,et al.  Incidence and aetiologies of pulmonary granulomatous inflammation: A decade of experience , 2015, Respirology.

[68]  D. Gray,et al.  Lung function abnormalities in HIV‐infected adults and children , 2015, Respirology.

[69]  T. Shim,et al.  Clinical characteristics of pulmonary arteriovenous malformations in Koreans , 2015, Respirology.

[70]  A. Horsley,et al.  Putting lung function and physiology into perspective: cystic fibrosis in adults , 2015, Respirology.

[71]  S. Molin,et al.  Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis , 2014, Nature Genetics.

[72]  N. Eves,et al.  Obesity negatively impacts lung function in children and adolescents , 2014, Pediatric pulmonology.

[73]  Emily A. Knapp,et al.  Children and young adults with CF in the USA have better lung function compared with the UK , 2014, Thorax.

[74]  J. Bradley,et al.  Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasis. , 2014, American journal of respiratory and critical care medicine.

[75]  J. Salleron,et al.  Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. , 2013, Chest.

[76]  P. Lee,et al.  Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. , 2013, The Lancet. Respiratory medicine.

[77]  Shandra L. Protzko,et al.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. , 2013, American journal of respiratory and critical care medicine.

[78]  D. Schwartz,et al.  The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population , 2013, PloS one.

[79]  Naftali Kaminski,et al.  Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. , 2013, The Lancet. Respiratory medicine.

[80]  K. Anstrom,et al.  Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction. , 2013, Chest.

[81]  Brent S. Pedersen,et al.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.

[82]  A. Nicholson,et al.  Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis , 2013, Thorax.

[83]  S. Bojesen,et al.  Short telomere length, lung function and chronic obstructive pulmonary disease in 46 396 individuals , 2012, Thorax.

[84]  T. Desudchit,et al.  Clinical and polysomnographic data of positional sleep apnea and its predictors , 2012, Sleep and Breathing.

[85]  A. Campbell,et al.  Nasal versus oronasal continuous positive airway pressure masks for obstructive sleep apnea: a pilot investigation of pressure requirement, residual disease, and leak , 2012, Sleep and Breathing.

[86]  C. Pollak,et al.  The efficacy of three different mask styles on a PAP titration night. , 2012, Sleep medicine.

[87]  Kevin J Anstrom,et al.  Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. , 2012, The New England journal of medicine.

[88]  M. Armanios.  Telomerase and idiopathic pulmonary fibrosis. , 2012, Mutation research.

[89]  S. Sands,et al.  Phenotypes of patients with mild to moderate obstructive sleep apnoea as confirmed by cluster analysis , 2012, Respirology.

[90]  Ramon Farré,et al.  Oscillation mechanics of the respiratory system. , 2011, Comprehensive Physiology.

[91]  Ivana V. Yang,et al.  A common MUC5B promoter polymorphism and pulmonary fibrosis. , 2011, The New England journal of medicine.

[92]  I. Noth,et al.  A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. , 2011, The New England journal of medicine.

[93]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[94]  F. Martinez,et al.  Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[95]  Valerie Beral,et al.  Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study , 2009, BMJ : British Medical Journal.

[96]  K. Jones,et al.  Childhood obesity, BMI calculators, and medical software--time for an upgrade? , 2009, Australian family physician.

[97]  J. Herlitz,et al.  Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea – RICCADSA trial , 2009, Scandinavian cardiovascular journal : SCJ.

[98]  D. Porteous,et al.  Lung clearance index is a sensitive, repeatable and practical measure of airways disease in adults with cystic fibrosis , 2007, Thorax.

[99]  Chao Xing,et al.  Adult-onset pulmonary fibrosis caused by mutations in telomerase , 2007, Proceedings of the National Academy of Sciences.

[100]  P. Gustafsson,et al.  Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis , 2003, European Respiratory Journal.

[101]  M. Cherian,et al.  Pulmonary arteriovenous malformations. , 2001, Clinical radiology.

[102]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[103]  E. Abraham.  Coagulation abnormalities in acute lung injury and sepsis. , 2000, American journal of respiratory cell and molecular biology.

[104]  Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis. , 2015, The New England journal of medicine.

[105]  J. Elborn,et al.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. , 2015, The New England journal of medicine.

[106]  A. Azuma,et al.  A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis , 2015 .

[107]  Gregory G King,et al.  HIGHLIGHTED TOPIC Pulmonary Physiology and Pathophysiology in Obesity Physiology of obesity and effects on lung function , 2009 .

[108]  E. Spriggs.  The history of spirometry. , 1978, British journal of diseases of the chest.